C12N 7/02
Recovery or purification
C12N7/02 (Recovery or purification) appears on 175 US grants and 309 published applications in this corpus.
Search patents in C12N- Granted patents
- 175
- Published applications
- 309
- Assignees
- 181
- Inventors
- 663
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 3 |
| 2004 | 0 | 0 |
| 2005 | 2 | 1 |
| 2006 | 0 | 0 |
| 2007 | 2 | 0 |
| 2008 | 1 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 7 |
| 2011 | 4 | 7 |
| 2012 | 4 | 12 |
| 2013 | 8 | 22 |
| 2014 | 3 | 11 |
| 2015 | 8 | 7 |
| 2016 | 11 | 13 |
| 2017 | 8 | 9 |
| 2018 | 7 | 39 |
| 2019 | 20 | 32 |
| 2020 | 18 | 20 |
| 2021 | 20 | 22 |
| 2022 | 13 | 20 |
| 2023 | 12 | 18 |
| 2024 | 14 | 18 |
| 2025 | 11 | 16 |
| 2026 | 8 | 30 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- HIV viral load testing29 Sep 2026US 12,748,120 B2Diagnostics for the Real World, Ltd.
- Protein-based purification matrices and methods of using the same28 Jul 2026US 12,692,483 B2Donaldson Company, Inc.
- Methods for purifying bacteriophage and products of manufacture containing endotoxin-free bacteriophage preparations9 Jun 2026US 12,648,976 B2San Diego State University (SDSU) Foundation
- Cell lines for production of adeno-associated virus9 Jun 2026US 12,649,908 B2The University of North Carolina at Chapel Hill
- Hepatitis E virus-like particles (VLPs) derived from consensus sequences19 May 2026US 12,630,844 B2Novo Capsid Technologies LLC
- Adenoviral vector vaccine, and preparation method and use thereof10 Sep 2026US 2026/0265702 A1Cansino Biologics Inc.
- Packaging plasmids for aav production3 Sep 2026US 2026/0258449 A1Biogen MA Inc.
- Methods of Isolating Poxviruses from Avian Cell Cultures27 Aug 2026US 2026/0248906 A1Bavarian Nordic A/S
- Method for production of virus-like particles for gene delivery27 Aug 2026US 2026/0250644 A1Carnegie Mellon University
- Systems and methods for generating bacteriophages adapted to infect a target bacterial strain20 Aug 2026US 2026/0242749 A1Baylor College of Medicine
Most cited
By later US patents
- Complementing cell lines58US 6,974,695 B2Crucell Holland B. V. · 2005
- Complementing cell lines49US 6,492,169 B1Crucell Holland B. V. · 2002
- Complementing cell lines24US 6,869,794 B2Crucell Holland B. V. · 2005
- Purification of vaccinia viruses using hydrophobic interaction chromatography20US 8,003,364 B2Bavarian Nordic A/S · 2011
- Purification of vaccinia viruses using hydrophobic interaction chromatography16US 8,163,531 B2Bavarian Nordic A/S · 2012